CoChat

Interleukin-6 Serum Levels in Patients with Parkinson’s Disease

Open access

The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.

Abstract

Several lines of evidence suggest that neuroimmune mechanisms may be involved in the neurodegenerative process of Parkinson's disease (PD). Interleukin-6 (IL-6) is increased in the nigrostriatal region and in the cerebrospinal fluid of patients with PD. IL-6 serum level was evaluated in PD patients. The effects of levodopa treatment and disease severity on IL-6 were also studied. The IL-6 levels were similar between PD patients (treated and not treated) and controls. However, there was a negative correlation of IL-6 levels and the activities of daily living scale (P < 0.05), indicating that patients with more severe disease have higher levels of this cytokine. No correlation involving levodopa treatment and IL-6 serum level was found. The results suggest that only marginal effects of IL-6 occur on the peripheral immune system, and that the role of IL-6 and others neuroimmune factors needs to be well elucidated on PD.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11064-009-9921-z

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 1

  1. Schwab RS, England AC (1969) Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson MC (eds) Third symposium on Parkinson’s disease, Livingstone, pp 152–157

Cited by

See all 98

Metadata

Authors
Hofmann, K. W., Schuh, A. F. S., Saute, J., Townsend, R., Fricke, D., Leke, R., Souza, D. O., Portela, L. V., Chaves, M. L. F., & Rieder, C. R. M.
Affiliations
  • Hospital de Clínicas de Porto Alegre (BR)
  • Universidade Federal do Rio Grande do Sul (BR)
Venue
Neurochemical Research
Published
2009-02-13
Volume
34
Issue
8
Pages
1401-1404
ISSN
  • 0364-3190 (ISSN-L)
  • 1573-6903
OpenAlex
W2139284698
Cited by
98
References
27
Citations by year
2026: 4 · 2025: 6 · 2024: 9 · 2023: 16 · 2022: 5 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 2 · 2012: 7
FWCI
2.56
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc-sa
  • www.springer.com/tdm (tdm)
Locations
  • Neurochemical Research (publishedVersion)
  • PubMed (publishedVersion)
  • Lume (Universidade Federal do Rio Grande do Sul) (submittedVersion, cc-by-nc-sa)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
interleukin-6, Parkinson's disease, serum cytokine levels, neuroinflammation, neuroimmune mechanisms, levodopa therapy, disease severity, activities of daily living, peripheral immune system
MeSH terms
Activities of Daily Living, Aged, Antiparkinson Agents, Female, Humans, Levodopa, Male, Middle Aged, Parkinson Disease, Interleukin-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin-6 Serum Levels in Patients with Parkinson’s Disease. https://app.cochat.ai/papers/10.1007/s11064-009-9921-z
The paper
Hofmann, K. W., Schuh, A. F. S., Saute, J., Townsend, R., Fricke, D., Leke, R., Souza, D. O., Portela, L. V., Chaves, M. L. F., & Rieder, C. R. M. (2009). Interleukin-6 Serum Levels in Patients with Parkinson’s Disease. Neurochemical Research. https://doi.org/10.1007/s11064-009-9921-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.